H5N1 avian influenza vaccine (Xiamen Innovax Biotech)

N/A

Report date: 2025/03/20 14:44:42

Base Information

Drug NameH5N1 avian influenza vaccine (Xiamen Innovax Biotech)
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccineBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody murine
Mechanisms of ActionInfluenza virus replication inhibitors
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesXiamen Innovax Biotech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesXiamen Innovax Biotech Co LtdXiamen University
Inactive CompaniesN/A
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A